ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974

In Brief: Arlan Gottlieb, CALGB Leader, Dead At 55; NCI’s John Cooper Undergoes Heart Transplant

July 7, 1989

NCCS Networker Volume 3 Issue 3, Summer 1989

June 13, 1989

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues

January 22, 1988

NCAB To Seek Changes In Cancer Act Renewal, Budget Improvements

November 20, 1987